Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9545 |
High Similarity |
NPD3882 |
Suspended |
0.9045 |
High Similarity |
NPD2801 |
Approved |
0.8981 |
High Similarity |
NPD1934 |
Approved |
0.8896 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8896 |
High Similarity |
NPD6166 |
Phase 2 |
0.8896 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8839 |
High Similarity |
NPD1512 |
Approved |
0.8834 |
High Similarity |
NPD3926 |
Phase 2 |
0.8805 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8788 |
High Similarity |
NPD3818 |
Discontinued |
0.875 |
High Similarity |
NPD3817 |
Phase 2 |
0.8712 |
High Similarity |
NPD1247 |
Approved |
0.871 |
High Similarity |
NPD1511 |
Approved |
0.8589 |
High Similarity |
NPD919 |
Approved |
0.8535 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8466 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8421 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8412 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8363 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8353 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8344 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8314 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8294 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8284 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8256 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8246 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8205 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8198 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8171 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD1240 |
Approved |
0.817 |
Intermediate Similarity |
NPD943 |
Approved |
0.816 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8153 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8075 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8065 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8025 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7977 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7975 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD920 |
Approved |
0.7904 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7892 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7875 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7875 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7866 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7857 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7744 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7744 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7744 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7744 |
Intermediate Similarity |
NPD2532 |
Approved |
0.773 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7628 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7614 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7595 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7595 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7546 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7541 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7527 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD2163 |
Approved |
0.75 |
Intermediate Similarity |
NPD9494 |
Approved |
0.75 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7486 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7326 |
Intermediate Similarity |
NPD37 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7302 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7301 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7299 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7284 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7258 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7256 |
Intermediate Similarity |
NPD6100 |
Approved |
0.725 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7247 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7193 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7191 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7191 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7191 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7143 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7127 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7118 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8313 |
Approved |
0.707 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7049 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7045 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7037 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.701 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.701 |
Intermediate Similarity |
NPD6779 |
Approved |
0.701 |
Intermediate Similarity |
NPD6780 |
Approved |
0.701 |
Intermediate Similarity |
NPD4665 |
Approved |
0.701 |
Intermediate Similarity |
NPD6781 |
Approved |
0.701 |
Intermediate Similarity |
NPD6782 |
Approved |
0.701 |
Intermediate Similarity |
NPD6777 |
Approved |
0.701 |
Intermediate Similarity |
NPD6776 |
Approved |
0.701 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD2798 |
Approved |
0.699 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6989 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6988 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6985 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6977 |
Remote Similarity |
NPD5049 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD2494 |
Approved |
0.6974 |
Remote Similarity |
NPD2493 |
Approved |
0.6973 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6962 |
Remote Similarity |
NPD1608 |
Approved |
0.6957 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD3887 |
Approved |
0.6933 |
Remote Similarity |
NPD3268 |
Approved |
0.6933 |
Remote Similarity |
NPD411 |
Approved |
0.6927 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD9268 |
Approved |
0.691 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD2353 |
Approved |
0.6905 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6899 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6891 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6891 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6888 |
Remote Similarity |
NPD3450 |
Approved |
0.6888 |
Remote Similarity |
NPD3452 |
Approved |
0.6886
|
Remote Similarity |
NPD4308 |
Phase 3 |